1405 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
RSS Create an RSS feed from your search for:
"Sexually Transmitted Diseases, Viral"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse
Conditions: Alcoholism;   Child Abuse, Sexual;   Sexual Abuse;   Sexual Behavior;   Sexually Transmitted Diseases, Viral
Intervention: Behavioral: Trauma-focused group therapy
2 Completed Measuring Responses to Sublingual Antigens
Condition: Sexually Transmitted Diseases, Viral
Intervention: Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
3 Completed HIV Prevention Intervention for Couples
Condition: Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Couples HIV counseling and testing;   Behavioral: Women's relationship-focused HIV counseling and testing
4 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
5 Terminated The Mochudi Prevention Project ART Protocol
Condition: HIV Infections
Intervention: Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, Emtricitabine
6 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
7 Recruiting Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Condition: Acute HIV Infection
Interventions: Drug: cART(TDF/AZT+3TC+LPV/r);   Procedure: CTL infusion
8 Recruiting Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV
Condition: HIV-infection
Intervention: Drug: Angiotensin II Infusion
9 Recruiting AIDS 347: IL-6 Blockade in Treated HIV Infection
Condition: HIV Infections
Interventions: Drug: tocilizumab;   Drug: Placebo
10 Completed Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults
Conditions: Cholera;   Vibrio Infections;   Diarrhea
Interventions: Biological: CholeraGarde®;   Biological: Placebo
11 Completed
Has Results
Exercise, Oxidative Stress and HIV
Condition: HIV Infections
Intervention:
12 Not yet recruiting Pharmacokinetics Study of GSK1265744 in Subjects With Severe Renal Impairment
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1265744 30 mg
13 Completed A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome
Conditions: Cachexia;   HIV Infections;   HIV Wasting Syndrome
Interventions: Drug: Dronabinol;   Drug: Megestrol acetate
14 Completed A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules
Condition: HIV Infections
Intervention: Biological: gp160 Vaccine (Immuno-AG)
15 Completed Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring
Condition: HIV Infections
Interventions: Drug: Dapivirine Vaginal Ring;   Drug: Maraviroc Vaginal Ring;   Other: Placebo Vaginal Ring;   Drug: Dapivirine-Maraviroc Vaginal Ring
16 Completed An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects
Condition: HIV Infections
Intervention: Drug: Alovudine
17 Completed HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)
Conditions: HIV-Associated Lipodystrophy Syndrome;   Cardiovascular Disease
Interventions: Drug: Lamivudine;   Drug: Stavudine;   Drug: Didanosine;   Drug: Zidovudine;   Drug: Tenofovir;   Drug: Abacavir;   Drug: Efavirenz (EFV);   Drug: Nevirapine;   Drug: Indinavir;   Drug: Saquinavir;   Drug: Amprenavir;   Drug: Ritonavir;   Drug: Nelfinavir;   Drug: Tipranavir;   Drug: enfuvirtide (T20)
18 Completed Buprenorphine and Integrated HIV Care
Conditions: Substance-related Disorders;   Drug Addiction;   Human Immunodeficiency Virus;   AIDS;   HIV Infections
Interventions: Other: Physician Management;   Behavioral: Counseling
19 Completed Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
Conditions: Acquired Immunodeficiency Syndrome;   Kaposi's Sarcoma;   Leukemia;   Lymphoma;   Tumor Virus Infection;   HIV Infections
Intervention:
20 Completed A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC)
Condition: HIV Infections
Intervention: Drug: Inosine pranobex

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years